Tampa General Hospital and Florida Urology Partners Perform First Aquablation Therapy

The procedure treats a common condition in men with no incisions and no heat.

Tampa, FL (Nov. 16, 2023) – Tampa General Hospital (TGH) and Florida Urology Partners have performed the first-ever Aquablation procedure for the treatment of benign prostatic hyperplasia (BPH). This minimally invasive, groundbreaking procedure utilizes image-guided, high-precision waterjet technology.

The procedure was conducted by Dr. Raviender Bukkapatnam, president of Florida Urology Partners, chief of TGH Urology Institute, Quality Committee Chair to the Board of Directors at Tampa General Hospital and TGH Foundation Board of Trustees. This achievement showcases Tampa General Hospital's commitment to offering state-of-the-art medical procedures to patients affected by benign prostatic hyperplasia.

Aquablation is a no-incision, no-heat procedure that uses a high-pressure waterjet controlled by robotic technology to precisely remove excess prostate tissue to relieve BPH symptoms. BPH is a common condition in men, characterized by the enlargement of the prostate gland, leading to urinary difficulties. Aquablation offers an innovative approach to address this issue, combining the accuracy of robotics with the gentleness of water. This innovative therapy offers long-term relief to BPH symptoms with a low risk of side effects or complications.

Aquablation therapy is specifically designed to treat BPH, providing relief from symptoms such as urinary urgency, frequent urination and weak urine flow. It offers a less-invasive alternative to traditional surgical treatments, promising a better quality of life for those suffering from this condition. Patients often experience rapid symptom relief and a substantial improvement in their overall quality of life. The procedure's precision reduces the risk of complications, making it a compelling choice for individuals seeking treatment for BPH.

Florida Urology Partners is a nationally recognized urologic specialty consortium which provides world-class comprehensive care and treatment for a wide range of conditions, including highly complex urological and other closely related cancers. Their team of experienced urologists is dedicated to staying at the forefront of medical advancements to provide top-notch care to patients across the Tampa Bay region and is proud to offer Aquablation as part of their clinical practice.

"Aquablation therapy represents a significant step forward in urological care, and Florida Urology Partners, in collaboration with Tampa General Hospital, are committed to delivering the most advanced and effective treatments," Bukkapatnam said.

Tampa General Hospital stands as a premier health care institution with a long-standing commitment to providing cutting-edge medical procedures and exceptional patient care. Equipped with state-of-the-art facilities and a highly skilled medical team, the hospital has consistently led the way in medical innovation.

"This milestone of performing the first Aquablation therapy at Tampa General Hospital reflects our dedication to offering the best in health care. We are proud to make innovative treatments like this available to our patients," Bukkapatnam said.